. 2021 Apr 13;11(2):421–429. doi: 10.3233/JPD-202184
© 2021 – The authors. Published by IOS Press
This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig.3.
Overview of trials and compounds in phase 2 trials.